Focusing on You: Clinical Trial for Alzheimer’s Patients

1 min read  |  March 18, 2019  | 

Dr. Bernard Baumel, the neurologist at UHealth, the University of Miami Health System, discusses the T2 Protect AD clinical trial, a study that looks at the effectiveness of a new drug to slow the progression of Alzheimer’s disease. Click here for the full story on TZ Protect AD, including enrollment requirements.

Tags: Alzheimer's Disease, clinical trials, Dr. Bernard Baumel, T2 Protect AD

Continue Reading